Analysis of Antiinfective Medicine Sales in Finland shows a significant growth trend over the years, with fluctuations. The sales value in 2023 is positioned at 304.1 million USD. The past two years have shown small but positive variations, with a year-on-year increase of 2.45% in 2022 and 2.36% in 2023, demonstrating a slight recovery after previous declines. For the last five years, the Compound Annual Growth Rate (CAGR) averaged at a moderate 0.84%.
Future projections up to 2028 suggest a steady increase in sales at a forecast 5-year CAGR of 1.72%, resulting in an overall growth rate of 8.9%. Key trends to watch include the impact of healthcare policies, emerging antibiotic resistance, and the introduction of new antiinfective drugs.
